These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 27494946

  • 1. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
    Janssen PK, Foudraine NA, Burgers DM, Neef K, le Noble JL.
    Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
    [Abstract] [Full Text] [Related]

  • 2. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Roger C, Wallis SC, Muller L, Saissi G, Lipman J, Lefrant JY, Roberts JA.
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Radej J, Krouzecky A, Stehlik P, Sykora R, Chvojka J, Karvunidis T, Novak I, Matejovic M.
    Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P, Kijkriengkraikul N, Leelahavanichkul A, Srisawat N, Praditpornsilpa K, Eiam-Ong S.
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [Abstract] [Full Text] [Related]

  • 7. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
    Roger C, Cotta MO, Muller L, Wallis SC, Lipman J, Lefrant JY, Roberts JA.
    Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A, Gascón AR, Maynar J, Arzuaga A, Toral D, Pedraz JL.
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [Abstract] [Full Text] [Related]

  • 11. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
    Palsson R, Niles JL.
    Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
    [Abstract] [Full Text] [Related]

  • 12. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
    Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A.
    BMC Nephrol; 2013 Oct 25; 14():232. PubMed ID: 24156306
    [Abstract] [Full Text] [Related]

  • 13. Continuous renal replacement therapy: a potential source of calories in the critically ill.
    New AM, Nystrom EM, Frazee E, Dillon JJ, Kashani KB, Miles JM.
    Am J Clin Nutr; 2017 Jun 25; 105(6):1559-1563. PubMed ID: 28468893
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
    Gao C, Tong J, Yu K, Sun Z, An R, Du Z.
    Eur J Clin Pharmacol; 2016 Jul 25; 72(7):823-30. PubMed ID: 27023465
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.